<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31772352</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Nov</Month><Day>26</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Short echo-time Magnetic Resonance Spectroscopy in ALS, simultaneous quantification of glutamate and GABA at 3&#x2009;T.</ArticleTitle><Pagination><StartPage>17593</StartPage><MedlinePgn>17593</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">17593</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-53009-4</ELocationID><Abstract><AbstractText>Cortical hyperexcitability has been found in early Amyotrophic Lateral Sclerosis (ALS) and is hypothesized to be a key factor in pathogenesis. The current pilot study aimed to investigate cortical inhibitory/excitatory balance in ALS using short-echo Magnetic Resonance Spectroscopy (MRS). Patients suffering from ALS were scanned on a 3&#x2009;T Trio Siemens MR scanner using Spin Echo Full Intensity Acquired Localized (SPECIAL) Magnetic Resonance Spectroscopy in primary motor cortex and the occipital lobe. Data was compared to a group of healthy subjects. Nine patients completed the scan. MRS data was of an excellent quality allowing for quantification of a range of metabolites of interest in ALS. In motor cortex, patients had Glutamate/GABA and GABA/Cr- ratios comparable to healthy subjects. However, Glutamate/Cr (p&#x2009;=&#x2009;0.002) and the neuronal marker N-acetyl-aspartate (NAA/Cr) (p&#x2009;=&#x2009;0.034) were low, possibly due to grey-matter atrophy, whereas Glutathione/Cr (p&#x2009;=&#x2009;0.04) was elevated. In patients, NAA levels correlated significantly with both hand strength (p&#x2009;=&#x2009;0.027) and disease severity (p&#x2009;=&#x2009;0.016). In summary SPECIAL MRS at 3&#x2009;T allows of reliable quantification of a range of metabolites of interest in ALS, including both excitatory and inhibitory neurotransmitters. The method is a promising new technique as a biomarker for future studies on ALS pathophysiology and monitoring of disease progression.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Blicher</LastName><ForeName>J U</ForeName><Initials>JU</Initials><AffiliationInfo><Affiliation>Center of Functionally Integrative Neuroscience (CFIN), Aarhus University, Aarhus, Denmark. jbli@cfin.au.dk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Aarhus University Hospital, Aarhus, Denmark. jbli@cfin.au.dk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eskildsen</LastName><ForeName>S F</ForeName><Initials>SF</Initials><Identifier Source="ORCID">0000-0003-4242-9158</Identifier><AffiliationInfo><Affiliation>Center of Functionally Integrative Neuroscience (CFIN), Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>St&#xe6;rmose</LastName><ForeName>T G</ForeName><Initials>TG</Initials><AffiliationInfo><Affiliation>Center of Functionally Integrative Neuroscience (CFIN), Aarhus University, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>M&#xf8;ller</LastName><ForeName>A T</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figlewski</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Near</LastName><ForeName>J</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-3516-936X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry, McGill University, Montreal, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>11</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0RH81L854J</RegistryNumber><NameOfSubstance UI="D005973">Glutamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>3KX376GY7L</RegistryNumber><NameOfSubstance UI="D018698">Glutamic Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>4L6452S749</RegistryNumber><NameOfSubstance UI="D007294">Inositol</NameOfSubstance></Chemical><Chemical><RegistryNumber>56-12-2</RegistryNumber><NameOfSubstance UI="D005680">gamma-Aminobutyric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>997-55-7</RegistryNumber><NameOfSubstance UI="C000179">N-acetylaspartate</NameOfSubstance></Chemical><Chemical><RegistryNumber>GAN16C9B8O</RegistryNumber><NameOfSubstance UI="D005978">Glutathione</NameOfSubstance></Chemical><Chemical><RegistryNumber>MU72812GK0</RegistryNumber><NameOfSubstance UI="D003401">Creatine</NameOfSubstance></Chemical><Chemical><RegistryNumber>N91BDP6H0X</RegistryNumber><NameOfSubstance UI="D002794">Choline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName><QualifierName UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002794" MajorTopicYN="N">Choline</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003401" MajorTopicYN="N">Creatine</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018698" MajorTopicYN="N">Glutamic Acid</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005973" MajorTopicYN="N">Glutamine</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005978" MajorTopicYN="N">Glutathione</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018737" MajorTopicYN="N">Hand Strength</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007294" MajorTopicYN="N">Inositol</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="N">Motor Cortex</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009778" MajorTopicYN="N">Occipital Lobe</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="N">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016037" MajorTopicYN="N">Single-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005680" MajorTopicYN="N">gamma-Aminobutyric Acid</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="Y">analysis</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31772352</ArticleId><ArticleId IdType="pmc">PMC6879471</ArticleId><ArticleId IdType="doi">10.1038/s41598-019-53009-4</ArticleId><ArticleId IdType="pii">10.1038/s41598-019-53009-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vucic S, Kiernan MC. Pathophysiology of neurodegeneration in familial amyotrophic lateral sclerosis. Curr Mol Med. 2009;9:255&#x2013;272. doi: 10.2174/156652409787847173.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652409787847173</ArticleId><ArticleId IdType="pubmed">19355908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, et al. Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology. 2007;68:1402&#x2013;1410. doi: 10.1212/01.wnl.0000260065.57832.87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260065.57832.87</ArticleId><ArticleId IdType="pubmed">17452585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, et al. Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology. 2006;239:831&#x2013;838. doi: 10.1148/radiol.2393050573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2393050573</ArticleId><ArticleId IdType="pubmed">16641339</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Welsh RC, Feldman EL. 25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol. 2013;9:513&#x2013;524. doi: 10.1038/nrneurol.2013.153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.153</ArticleId><ArticleId IdType="pmc">PMC4182931</ArticleId><ArticleId IdType="pubmed">23917850</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioro EP, Antel JP, Cashman NR, Arnold DL. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology. 1994;44:1933&#x2013;1938. doi: 10.1212/WNL.44.10.1933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.10.1933</ArticleId><ArticleId IdType="pubmed">7936250</ArticleId></ArticleIdList></Reference><Reference><Citation>Gredal O, et al. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology. 1997;48:878&#x2013;881. doi: 10.1212/WNL.48.4.878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.48.4.878</ArticleId><ArticleId IdType="pubmed">9109871</ArticleId></ArticleIdList></Reference><Reference><Citation>Gredal, O., Pakkenberg, H., Karlsborg, M. &amp; Pakkenberg, B. Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis: a stereological study. J Neurosci Methods95, 171&#x2013;176 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10752488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalra Sanjay, Tai Peter, Genge Angela, Arnold Douglas L. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. Journal of Neurology. 2006;253(8):1060&#x2013;1063. doi: 10.1007/s00415-006-0162-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0162-7</ArticleId><ArticleId IdType="pubmed">16609809</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, et al. Decreased motor cortex gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology. 2012;78:1596&#x2013;1600. doi: 10.1212/WNL.0b013e3182563b57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182563b57</ArticleId><ArticleId IdType="pmc">PMC3348851</ArticleId><ArticleId IdType="pubmed">22517106</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, et al. An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol. 2013;70:1009&#x2013;1016. doi: 10.1001/jamaneurol.2013.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.234</ArticleId><ArticleId IdType="pmc">PMC4382938</ArticleId><ArticleId IdType="pubmed">23797905</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, et al. Ultra high-field (7tesla) magnetic resonance spectroscopy in Amyotrophic Lateral Sclerosis. PLoS One. 2017;12:e0177680. doi: 10.1371/journal.pone.0177680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177680</ArticleId><ArticleId IdType="pmc">PMC5428977</ArticleId><ArticleId IdType="pubmed">28498852</ArticleId></ArticleIdList></Reference><Reference><Citation>Near J, et al. Unedited in vivo detection and quantification of gamma-aminobutyric acid in the occipital cortex using short-TE MRS at 3 T. NMR Biomed. 2013;26:1353&#x2013;1362. doi: 10.1002/nbm.2960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2960</ArticleId><ArticleId IdType="pubmed">23696182</ArticleId></ArticleIdList></Reference><Reference><Citation>Near J, Simpson R, Cowen P, Jezzard P. Efficient gamma-aminobutyric acid editing at 3T without macromolecule contamination: MEGA-SPECIAL. NMR Biomed. 2011;24:1277&#x2013;1285. doi: 10.1002/nbm.1688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1688</ArticleId><ArticleId IdType="pubmed">21387450</ArticleId></ArticleIdList></Reference><Reference><Citation>Waddell KW, Avison MJ, Joers JM, Gore JC. A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging. 2007;25:1032&#x2013;1038. doi: 10.1016/j.mri.2006.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mri.2006.11.026</ArticleId><ArticleId IdType="pmc">PMC2131736</ArticleId><ArticleId IdType="pubmed">17707165</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Ma L. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging. 2010;31:305&#x2013;308. doi: 10.1002/jmri.22053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.22053</ArticleId><ArticleId IdType="pubmed">20099342</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, Bowen BC, Pattany PM, Rotta F. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci. 1999;169:84&#x2013;86. doi: 10.1016/S0022-510X(99)00221-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00221-X</ArticleId><ArticleId IdType="pubmed">10540013</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen BC, et al. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol. 2000;21:647&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pubmed">10782773</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong I, et al. Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis. Neurochem Res. 2017;42:1833&#x2013;1844. doi: 10.1007/s11064-017-2248-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2248-2</ArticleId><ArticleId IdType="pmc">PMC5488866</ArticleId><ArticleId IdType="pubmed">28367604</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagg CJ, et al. Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex. J Physiol. 2011;589:5845&#x2013;5855. doi: 10.1113/jphysiol.2011.216978.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2011.216978</ArticleId><ArticleId IdType="pmc">PMC3249054</ArticleId><ArticleId IdType="pubmed">22005678</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lazzaro V, et al. Effects of repetitive TMS of the motor cortex on disease progression and on glutamate and GABA levels in ALS: A proof of principle study. Brain Stimul. 2017;10:1003&#x2013;1005. doi: 10.1016/j.brs.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brs.2017.05.003</ArticleId><ArticleId IdType="pubmed">28545769</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiduschat N, et al. Motor cortex glutathione deficit in ALS measured in vivo with the J-editing technique. Neurosci Lett. 2014;570:102&#x2013;107. doi: 10.1016/j.neulet.2014.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2014.04.020</ArticleId><ArticleId IdType="pubmed">24769125</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) J Neurol Sci. 1999;169:13&#x2013;21. doi: 10.1016/S0022-510X(99)00210-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Figlewski K, et al. Decreased GABA levels in the symptomatic hemisphere in patients with transient ischemic attack. Heliyon. 2018;4:e00790. doi: 10.1016/j.heliyon.2018.e00790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2018.e00790</ArticleId><ArticleId IdType="pmc">PMC6154475</ArticleId><ArticleId IdType="pubmed">30258993</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousry TA, et al. Localization of the motor hand area to a knob on the precentral gyrus. A new landmark. Brain. 1997;120(Pt 1):141&#x2013;157. doi: 10.1093/brain/120.1.141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/120.1.141</ArticleId><ArticleId IdType="pubmed">9055804</ArticleId></ArticleIdList></Reference><Reference><Citation>Gruetter R, Tkac I. Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med. 2000;43:319&#x2013;323. doi: 10.1002/(SICI)1522-2594(200002)43:2&lt;319::AID-MRM22&gt;3.0.CO;2-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1522-2594(200002)43:2&lt;319::AID-MRM22&gt;3.0.CO;2-1</ArticleId><ArticleId IdType="pubmed">10680699</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson R, Devenyi GA, Jezzard P, Hennessy TJ, Near J. Advanced processing and simulation of MRS data using the FID appliance (FID-A)-An open source, MATLAB-based toolkit. Magn Reson Med. 2017;77:23&#x2013;33. doi: 10.1002/mrm.26091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.26091</ArticleId><ArticleId IdType="pubmed">26715192</ArticleId></ArticleIdList></Reference><Reference><Citation>Near J, et al. Frequency and phase drift correction of magnetic resonance spectroscopy data by spectral registration in the time domain. Magn Reson Med. 2015;73:44&#x2013;50. doi: 10.1002/mrm.25094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.25094</ArticleId><ArticleId IdType="pmc">PMC5851009</ArticleId><ArticleId IdType="pubmed">24436292</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>